34 filings
Page 2 of 2
8-K
2z58x7
5 Aug 21
Codiak BioSciences Reports Second Quarter 2021 Financial Results and Operational Progress
4:08pm
8-K
n8b6m755pfy xs
6 Jul 21
Departure of Directors or Certain Officers
5:01pm
8-K
vkgpzfk3yg0zfh7izgv
23 Jun 21
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
s4kxgdmudix
20 May 21
Departure of Directors or Certain Officers
5:00pm
8-K
hp9x4qb2
10 May 21
Codiak Appoints Jennifer Wheler, M.D., as Chief Medical Officer
5:18pm
8-K
hp65llmfwnkv2kl co
6 May 21
Codiak BioSciences Reports First Quarter 2021 Financial Results and Operational Progress
4:10pm
8-K
rm7qqjk4c9j
8 Apr 21
Regulation FD Disclosure
4:05pm
8-K
20mli92b1z1
26 Mar 21
Departure of Directors or Certain Officers
4:05pm
8-K
ogbmu8j
17 Mar 21
Codiak BioSciences Reports Fourth Quarter and Full Year 2020 Financial Results
7:44am
8-K
v78 h89bx
8 Mar 21
Departure of Directors or Certain Officers
5:18pm
8-K
et5tmowt154vgle
4 Feb 21
Codiak Reports Additional Positive Phase 1 Results for exoIL-12™ Confirming
8:46am
8-K
z7tf0jo
26 Jan 21
Departure of Directors or Certain Officers
4:39pm
8-K
aerjzvpolb rgd
30 Dec 20
Codiak Reports Positive Initial Phase 1 Results for exoIL-12™ Demonstrating Tolerability and Absence of Systemic IL-12 Exposure in Healthy Volunteers
8:00am
8-K
n35t7
20 Nov 20
Codiak BioSciences Reports Third Quarter 2020 Financial Results and Operational Progress
4:32pm